COMMD5 as a tumor suppressor regulates several tumorigenic kinases: it inhibits epidermal growth factor receptor (EGFR) expression and phosphorylation in kidney cancers and suppresses the MAPK and PI3K/AKT signaling pathways in renal carcinoma and melanoma cells [32]. Here, COMMD5 is linked to melanoma.